{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:39:49Z","timestamp":1774546789893,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1067\/mjd.2000.107806","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:22:26Z","timestamp":1027556546000},"page":"S12-S17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"P2","title":["Imiquimod in clinical practice"],"prefix":"10.1067","volume":"43","author":[{"given":"Libby","family":"Edwards","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"RR14","key":"10.1067\/mjd.2000.107806_bib1","first-page":"1","article-title":"1993 sexually transmitted diseases treatment guidelines","volume":"42","author":"Centers for Disease Control and Prevention","year":"1993","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1067\/mjd.2000.107806_bib2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1056\/NEJM198610233151704","article-title":"Interferon therapy for condylomata acuminata","volume":"315","author":"Eron","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2000.107806_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jama.1988.03720040025021","article-title":"Natural interferon alfa for treatment of condylomata acuminata","volume":"259","author":"Friedman-Kien","year":"1988","journal-title":"JAMA"},{"key":"10.1067\/mjd.2000.107806_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self-administered topical 5% imiquimod cream for external anogenital warts","volume":"134","author":"Edwards","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.107806_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/AAC.42.4.789","article-title":"Imiquimod, a patient-applied immune-response modifier for treatment of external warts","volume":"42","author":"Beutner","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1067\/mjd.2000.107806_bib7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/517472","article-title":"A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod","volume":"178","author":"Tyring","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1067\/mjd.2000.107806_bib8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1346-8138.1998.tb02429.x","article-title":"Management of female genital warts with an analog of imiquimod 2% cream: a randomized, double-blind, placebo-controlled study","volume":"25","author":"Syed","year":"1998","journal-title":"J Dermatol"},{"key":"10.1067\/mjd.2000.107806_bib9","first-page":"71","article-title":"Systemically administered interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation: the influence of the cyclic low-dose therapy regimen\u2014results of a multicentre double-blind placebo-controlled clinical trial [letter]","volume":"72","author":"Gross","year":"1996","journal-title":"Genitourin Med"},{"key":"10.1067\/mjd.2000.107806_bib10","first-page":"99","article-title":"Systemic interferon \u03b1-2b increases the cure rate in laser treated patients with multiple persistent genital warts: a placebo-controlled study","volume":"67","author":"Petersen","year":"1991","journal-title":"Genitourin Med"},{"key":"10.1067\/mjd.2000.107806_bib11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-4362.1996.tb03635.x","article-title":"The cost of treating genital warts","volume":"35","author":"Strauss","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2000.107806_bib12","first-page":"69","article-title":"The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts","volume":"5","author":"Langley","year":"1999","journal-title":"Am J Manag Care"},{"key":"10.1067\/mjd.2000.107806_bib13","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0190-9622(99)70261-6","article-title":"Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream","volume":"41","author":"Beutner","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.107806_bib14","article-title":"Treatment of molluscum contagiosum with topical imiquimod [abstract 352]","author":"Smith","year":"1999"},{"key":"10.1067\/mjd.2000.107806_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1346-8138.1998.tb02403.x","article-title":"Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: a placebo-controlled, double-blind study","volume":"25","author":"Syed","year":"1998","journal-title":"J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200612860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200612860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:22:30Z","timestamp":1759267350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962200612860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["S0190962200612860"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2000.107806","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2000,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imiquimod in clinical practice","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mjd.2000.107806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}